Literature DB >> 24769731

Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.

B Wang1, M Xie1, R Li1, T K Owonikoko2, S S Ramalingam2, F R Khuri2, W J Curran1, Y Wang1, X Deng1.   

Abstract

Mcl-1 is a unique antiapoptotic Bcl2 family member with a short half-life due to its rapid turnover through ubiquitination. We discovered that Ku70, a DNA double-strand break repair protein, functions as a deubiquitinase to stabilize Mcl-1. Ku70 knockout in mouse embryonic fibroblast (MEF) cells or depletion from human lung cancer H1299 cells leads to the accumulation of polyubiquitinated Mcl-1 and a reduction in its half-life and protein expression. Conversely, expression of exogenous Ku70 in Ku70(-/-) MEF cells restores Mcl-1 expression. Subcellular fractionation indicates that Ku70 extensively colocalizes with Mcl-1 in mitochondria, endoplasmic reticulum and nucleus in H1299 cells. Ku70 directly interacts with Mcl-1 via its C terminus (that is, aa 536-609), which is required and sufficient for deubiquitination and stabilization of Mcl-1, leading to suppression of apoptosis. Purified Ku70 protein directly deubiquitinates Mcl-1 by removing K48-linked polyubiquitin chains. Ku70 knockdown not only promotes Mcl-1 turnover but also enhances antitumor efficacy of the BH3-mimetic ABT-737 in human lung cancer xenografts. These findings identify Ku70 as a novel Mcl-1 deubiquitinase that could be a potential target for cancer therapy by manipulating Mcl-1 deubiquitination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24769731      PMCID: PMC4207484          DOI: 10.1038/cdd.2014.42

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  46 in total

1.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

Review 2.  MG132, a proteasome inhibitor, induces apoptosis in tumor cells.

Authors:  Na Guo; Zhilan Peng
Journal:  Asia Pac J Clin Oncol       Date:  2012-05-15       Impact factor: 2.601

3.  Prokaryotic homologs of the eukaryotic DNA-end-binding protein Ku, novel domains in the Ku protein and prediction of a prokaryotic double-strand break repair system.

Authors:  L Aravind; E V Koonin
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

4.  Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases.

Authors:  X Deng; P Ruvolo; B Carr; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

5.  Bcl-2 phosphorylation required for anti-apoptosis function.

Authors:  T Ito; X Deng; B Carr; W S May
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

6.  MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.

Authors:  Aaron M Domina; Julie A Vrana; Mark A Gregory; Stephen R Hann; Ruth W Craig
Journal:  Oncogene       Date:  2004-07-08       Impact factor: 9.867

7.  The 3D solution structure of the C-terminal region of Ku86 (Ku86CTR).

Authors:  Richard Harris; Diego Esposito; Andrew Sankar; Joseph D Maman; John A Hinks; Laurence H Pearl; Paul C Driscoll
Journal:  J Mol Biol       Date:  2004-01-09       Impact factor: 5.469

8.  Prohibitin, an antiproliferative protein, is localized to mitochondria.

Authors:  E Ikonen; K Fiedler; R G Parton; K Simons
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

9.  p34Cdc28-mediated control of Cln3 cyclin degradation.

Authors:  J Yaglom; M H Linskens; S Sadis; D M Rubin; B Futcher; D Finley
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

10.  Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation.

Authors:  Zhaohui Jin; Fengqin Gao; Tammy Flagg; Xingming Deng
Journal:  J Biol Chem       Date:  2004-06-21       Impact factor: 5.157

View more
  34 in total

1.  Role of Ku70 in the apoptosis of inflamed dental pulp stem cells.

Authors:  Yequan Huang; Weiwei Qiao; Xinhuan Wang; Qian Gao; Yao Peng; Zhuan Bian; Liuyan Meng
Journal:  Inflamm Res       Date:  2018-07-14       Impact factor: 4.575

Review 2.  Survival control of malignant lymphocytes by anti-apoptotic MCL-1.

Authors:  Y Fernández-Marrero; S Spinner; T Kaufmann; P J Jost
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

3.  Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.

Authors:  Guo Chen; Andrew T Magis; Ke Xu; Dongkyoo Park; David S Yu; Taofeek K Owonikoko; Gabriel L Sica; Sarah W Satola; Suresh S Ramalingam; Walter J Curran; Paul W Doetsch; Xingming Deng
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

4.  Two-way crosstalk between BER and c-NHEJ repair pathway is mediated by Pol-β and Ku70.

Authors:  Wen Xia; Shusheng Ci; Menghan Li; Meina Wang; Grigory L Dianov; Zhuang Ma; Lulu Li; Ke Hua; Karthick Kumar Alagamuthu; Lihong Qing; Libo Luo; Ashlin M Edick; Lingjie Liu; Zhigang Hu; Lingfeng He; Feiyan Pan; Zhigang Guo
Journal:  FASEB J       Date:  2019-07-26       Impact factor: 5.191

5.  PTH1-34 blocks radiation-induced osteoblast apoptosis by enhancing DNA repair through canonical Wnt pathway.

Authors:  Abhishek Chandra; Tiao Lin; Ji Zhu; Wei Tong; Yanying Huo; Haoruo Jia; Yejia Zhang; X Sherry Liu; Keith Cengel; Bing Xia; Ling Qin
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

6.  Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer.

Authors:  Fuquan Zhang; Mingjing Shen; Li Yang; Xiaodong Yang; Ying Tsai; Peter C Keng; Yongbing Chen; Soo Ok Lee; Yuhchyau Chen
Journal:  Cancer Biol Ther       Date:  2017-07-07       Impact factor: 4.742

Review 7.  Saga of Mcl-1: regulation from transcription to degradation.

Authors:  Viacheslav V Senichkin; Alena Y Streletskaia; Anna S Gorbunova; Boris Zhivotovsky; Gelina S Kopeina
Journal:  Cell Death Differ       Date:  2020-01-06       Impact factor: 15.828

8.  Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.

Authors:  Mi Jeong Kim; Guo Chen; Gabriel L Sica; Xingming Deng
Journal:  Cancer Biol Ther       Date:  2020-12-18       Impact factor: 4.742

9.  Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.

Authors:  Guo Chen; Dongkyoo Park; Andrew T Magis; Madhusmita Behera; Suresh S Ramalingam; Taofeek K Owonikoko; Gabriel L Sica; Keqiang Ye; Chao Zhang; Zhengjia Chen; Walter J Curran; Xingming Deng
Journal:  Cancer Res       Date:  2019-10-29       Impact factor: 12.701

10.  Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.

Authors:  Violetta Ritter; Franziska Krautter; Diana Klein; Verena Jendrossek; Justine Rudner
Journal:  Cell Death Dis       Date:  2021-07-13       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.